AVNS Avanos Medical Inc

  1. Stocks
  2. Healthcare
  3. NYSE: AVNS

Price (delayed)

$24.965

Market cap

$1.17B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.6

Enterprise value

$1.24B

?
Relative Growth: Rel. Growth: 46
Relative Strength: Rel. Strength: 93
Relative Valuation: Rel. Valuation: 23
Relative Profitability: Rel. Profitability: 40

Avanos Medical, Inc. is a medical technology company focused on delivering clinical medical device solutions. The company consists of two franchises – Pain Management and Chronic Care – that address ...

Highlights
The EPS has soared by 81% YoY
The revenue is up by 3.9% year-on-year and by 2.1% since the previous quarter
The net income has soared by 81% YoY but it has decreased by 2.1% from the previous quarter
The quick ratio has declined by 12% year-on-year but it has increased by 10% since the previous quarter
The gross margin has declined by 8% year-on-year
Avanos Medical's debt has increased by 7% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: https://avanos.com/
Peers: STE SYK

Key stats

What are the main financial stats of AVNS

AVNS stock price

How has the Avanos Medical stock price performed over time
Intraday
-0.06%
1 week
0.83%
1 month
1.24%
1 year
100.2%
YTD
122.31%
QTD
78.19%

Financial performance

How have Avanos Medical's revenue and profit performed over time
Revenue
$715.9M
Gross profit
$358.3M
Operating income
-$59.4M
Net income
-$74.4M
Gross margin
50%
Net margin
-10.4%
Avanos Medical's operating margin has soared by 86% YoY and by 6% from the previous quarter
The operating income has soared by 85% YoY and by 4.2% QoQ
Avanos Medical's net margin has soared by 81% YoY
The net income has soared by 81% YoY but it has decreased by 2.1% from the previous quarter

Price vs fundamentals

How does AVNS's price correlate with its fundamentals

Growth

What is Avanos Medical's growth rate over time

Valuation

What is Avanos Medical stock price valuation
AVNS P/E details
P/E
N/A
P/B
1.48
P/S
1.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.73
The EPS has soared by 81% YoY
AVNS's price to book (P/B) is 113% more than its last 4 quarters average of 0.7 and 66% more than its 5-year quarterly average of 0.9
The company's equity fell by 7% YoY
The P/S is 103% higher than the last 4 quarters average of 0.8
The revenue is up by 3.9% year-on-year and by 2.1% since the previous quarter

Efficiency

How efficient is Avanos Medical business performance
The ROS has soared by 85% YoY but it has contracted by 2.4% from the previous quarter
AVNS's ROIC has soared by 83% YoY but it is down by 3.1% from the previous quarter
The return on assets has surged by 75% year-on-year but it has declined by 2.9% since the previous quarter
The ROE has soared by 74% YoY but it has contracted by 4.3% from the previous quarter

Dividends

What is AVNS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AVNS.

Financial health

How did Avanos Medical financials performed over time
The company's current ratio rose by 15% QoQ but it fell by 3.5% YoY
The quick ratio has declined by 12% year-on-year but it has increased by 10% since the previous quarter
Avanos Medical's debt is 82% less than its equity
Avanos Medical's debt has increased by 7% from the previous quarter
The company's equity fell by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.